Verified ProfileEN

Shanghai Shikangte Pharmaceutical Co.,Ltd.

Order verification — $199

Manufacturing · Chemical Drug Preparation Manufacturing

Verification dossier

Shanghai Shikangte Pharmaceutical Co.,Ltd. is a Chinese company based in Shanghai. The company operates in the chemical drug preparation manufacturing sector, within the broader manufacturing industry. Established 1995, the company has been operating for 31 years.

Sinolinks tracks Shanghai Shikangte Pharmaceutical Co.,Ltd. as part of our independent verification practice. The full 18-section verification report covers ownership, financial standing, regulatory standing, trade relationships, and operating credentials — reviewed by our Hong Kong-based expert and delivered in 24 hours.

Business scope

Licensed items: Production of sanitary products and disposable medical supplies; production of disinfectants (excluding hazardous chemicals); drug production; food production; production of disinfectants for infectious disease prevention. General items: Production of non-medical masks; production of Class I medical devices; technical services, technical development, technical consulting, technical exchange, technology transfer, technology promotion; sales of sanitary products and disposable medical supplies; online sales (excluding goods requiring licensing); health consulting services (excluding diagnosis and treatment services); food sales (pre-packaged foods only).

Independent verification

Order the full verified report on this company

An 18-section verification report on this Chinese company, expert-reviewed and delivered in English within 24 hours. We support clients in six languages. HK-entity invoicing.

Order verification — $199

Independent verification

Included in the full report

Full Chinese legal name

Registration identifier

Legal representative & senior officers

Beneficial ownership & equity history

Registered address & operating premises

Capital & recent annual filings

Verified contact channels

Branches, controlled entities & investments

Trademark & patent portfolio

Trade relationships

Regulatory standing review